Leaderboards/Multiple Myeloma Research and Treatments

Multiple Myeloma Research and Treatments

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
María‐Victoria Mateos
Sheba Medical Center
97
2
M. Dreyling
Ludwig-Maximilians-Universität München
83
3
Koichi Takahashi
The University of Texas MD Anderson Cancer Center
76
4
Marcelo C. Pasquini
Medical College of Wisconsin
76
5
Yeng F Her
Mayo Clinic
76
6
Jun Ma
Yantaishan Hospital
75
7
Danai Dima
Cleveland Clinic
66
8
Hemn Mohammadpour
Roswell Park Comprehensive Cancer Center
61
9
Krina K. Patel
The University of Texas MD Anderson Cancer Center
61
10
Roch Houot
Centre Hospitalier Universitaire de Rennes
59

Rising Stars Papers

1
6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells
Nature Communications|2026
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Hidetaka Uryu
The University of Texas MD Anderson Cancer Center
99
2
Joshua Rivera
Harvard University
90
3
Aishee Bag
Rutgers, The State University of New Jersey
89
4
Shammas Bajwa
University of Oklahoma Medical Center
87
5
Majid Jaberi‐Douraki
Kansas State University
87
6
Kailai Li
Zhujiang Hospital
82
7
Salomon Manier
Université de Lille
80
8
Beatrice M. Razzo
Sidney Kimmel Cancer Center
77
9
Sinan Xiong
National University of Singapore
74
10
Juan Du
Shanghai Changzheng Hospital
73

Emerging Leaders Papers

1
Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma
Nature Communications|2024
11 cit.
2
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
bioRxiv (Cold Spring Harbor Laboratory)|2023
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Sundar Jagannath
Mount Sinai Medical Center
99
2
Philippe Moreau
University College London
98
3
Amrita Krishnan
Oncode Institute
92
4
Saad Z. Usmani
Centre Hospitalier Universitaire de Toulouse
90
5
Jesús F. San Miguel
Centro de Investigación Biomédica en Red de Cáncer
89
6
Peter C. Grayson
MACOM (United States)
83
7
Peter M. Voorhees
University of North Carolina at Chapel Hill
81
8
Christopher J L Murray
University of Washington
75
9
Paul G. Richardson
Harvard University
74
10
Christina Fitzmaurice
University of Washington
70

All-Time Leaders Papers

1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
The Lancet|2022
15.1k cit.
2
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet|2020
9.4k cit.
3
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories
The Lancet|2018
2.9k cit.
4
The Global Burden of Cancer 2013
JAMA Oncology|2015
2.8k cit.
5
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology|2018
2.7k cit.
6
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
JAMA Oncology|2019
2.7k cit.
7
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
New England Journal of Medicine|2003
2.6k cit.
8
The State of US Health, 1990-2010
JAMA|2013
2.5k cit.
9
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
JAMA|2017
2.4k cit.
10
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
The Lancet|2013
2k cit.

Reagents for Multiple Myeloma Research and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

CRBN (D8H3S) Rabbit Monoclonal Antibody

Cited in 11 papers
#71810$169
View Evidence →Cell Signaling Technology

Aiolos (D1C1E) Rabbit Monoclonal Antibody

Cited in 11 papers
#15103$149
View Evidence →Cell Signaling Technology

p44/42 MAPK (Erk1/2) (137F5) Rabbit Monoclonal Antibody (Biotinylated)

Cited in 9 papers
#5013$556
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

TIGIT (E5Y1W) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 29 papers
#17046$865
View Evidence →Cell Signaling Technology

HIP2 (D27C4) Rabbit Monoclonal Antibody

Cited in 27 papers
#8226$161
View Evidence →Cell Signaling Technology

TPX2 Antibody

Cited in 14 papers
#8559$136
View Evidence →